Abstract
There is currently no information available on illness perception in primary cutaneous T-cell lymphomas (CTCL). The aim of this study was therefore to gather initial information on disease understanding and interpretation in patients with CTCL. Consecutive patients from a hospital-based primary cutaneous lymphoma ward completed the Revised Illness Perception Questionnaire (IPQ-R) on 2 consecutive visits. A total of 24 patients with different variants of CTCL were included in the study. Patients experienced their condition as being long-lasting, but not fundamentally affecting their lives. Patients had poor belief in personal control, but strong belief in treatment control. They did not show a good understanding of their disease, and had a moderately negative emotional response to their illness. In conclusion, the IPQ-R provides a feasible and reproducible tool for measurement and better understanding of illness perception in patients with CTCL. Knowledge of patients' attitudes towards their disease should enable optimization of the patient-physician relationship and patient care.
| Original language | English |
|---|---|
| Pages (from-to) | 381-385 |
| Number of pages | 5 |
| Journal | Acta Dermato-Venereologica |
| Volume | 96 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Mar 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adult
- Aged
- Aged, 80 and over
- Comprehension
- Cost of Illness
- Emotions
- Female
- Health Knowledge, Attitudes, Practice
- Humans
- Lymphoma, T-Cell, Cutaneous/diagnosis
- Male
- Middle Aged
- Neoplasm Staging
- Patient Education as Topic
- Perception
- Quality of Life
- Skin Neoplasms/diagnosis
- Surveys and Questionnaires
Fingerprint
Dive into the research topics of 'Illness Perception in Primary Cutaneous T-cell Lymphomas: What Patients Believe About Their Disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver